Harvard University

Home/Tag: Harvard University

This microchip that could reduce animal testing has designers excited

July 3, 2015 1.28am EDT Authors Donald Ingber, Founding Director of the Wyss Institute at Harvard University Dongeun Huh, Assistant professor, bioengineering at University of Pennsylvania Disclosure statement Donald Ingber owns shares in Emulate, Inc. and consults for the company. He receives funding from DARPA, FDA and NIH, which provides partial support to advance his organ on

Researchers develop a new means of killing harmful bacteria

Engineered particles are capable of producing toxins that are deadly to targeted bacteria. Helen Knight | MIT News Office June 25, 2015 The global rise in antibiotic resistance is a growing threat to public health, damaging our ability to fight deadly infections such as tuberculosis. What’s more, efforts to develop new antibiotics are not keeping

A New Grasp on Robotic Glove

Mon, 06/08/2015 - 10:15am- Harvard University The soft robotic glove could help patients suffering from muscular dystrophy, amyotrophic lateral sclerosis, incomplete spinal cord injury, or other hand impairments regain some independence and control of their environment. (Photo: Courtesy of Wyss Institute at Harvard University)Having achieved promising results in proof-of-concept prototyping and experimental testing, a soft robotic

Injectable nanoelectronics for treatment of neuro-degenerative diseases

June 8, 2015 - Harvard UniversityIt's a notion that might be pulled from the pages of science-fiction novel - electronic devices that can be injected directly into the brain, or other body parts, and treat everything from neurodegenerative disorders to paralysis. It sounds unlikely, until you visit Charles Lieber's lab. A team of international researchers,

MGH gives grant to low-cost sickle cell diagnostic

Mar 31, 2015 Jessica Bartlett Reporter-Boston Business Journal Massachusetts General Hospital’s Center for Global Health is helping to fund an affordable sickle cell diagnostic, awarding $100,000 to the Whitesides Research Group. Courtesy/Whitesides Research Group A density test can tell whether someone has sickle cell disease. The team, led by Harvard University Chemistry Professor George Whitesides, has been working

New trial to treat Alzheimer’s seen as “game changing”

ByWYATT ANDREWSCBS NEWS March 24, 2015, 7:32 PM BOSTON -- Helene DeCoste of Boston is a patient in a ground breaking clinical trial, testing whether a drug called Solanezumab can slow down or even prevent Alzheimer's disease. No drug has even come close before, but researchers have never tested patients quite like Helene in quite this

Type 1 diabetes breakthrough as stem cells make billions of human insulin cells

Medical News Today, by Catharine Paddock, PhD ~ October 10, 2014 In what is being described as an important advance in the field of stem cell research, a new study reveals how scientists successfully created billions of insulin-producing pancreatic beta cells from embryonic stem cells. Stem cells Stem cells are a class of undifferentiated cells

Amid ALS Mania, Possible Drug Target Spotted

Bioscience Technology, by Cynthia Fox ~ August 26, 2014 As, all around them, everyone from Derek Jeter to the Kennedy family was dousing themselves for the ALS “Ice Bucket Challenge,” Harvard University researchers announced last week they may have found an ALS therapy—or two. When they blocked the gene for prostanoid receptor DP1 in ALS-model

Patient stem cells used to make ‘heart disease-on-a-chip’

ScienceDaily, Source: Harvard University by Joseph Caputo ~ May 11, 2014 Harvard scientists have merged stem cell and 'organ-on-a-chip' technologies to grow, for the first time, functioning human heart tissue carrying an inherited cardiovascular disease. The research appears to be a big step forward for personalized medicine, as it is working proof that a chunk

Patient Stem Cell Models Lead Researchers to Promising ALS Trial

Project A.L.S., by Staff ~ April 11, 2014 A Project A.L.S. breakthrough recognized by Time magazine in 2008, has led scientists at Harvard University to a potential therapy for the disease. Two studies published this month utilizing iPS stem cell models—or “ALS in a Dish”—point to retigabine, a drug marketed for epilepsy, as a possibility